Fetal health assessment in utero by laboratory technologies: Clinical benefits, risks and controversies

Clinical Biochemistry

Volumn 44, Issue 7, 2011, Pages 460-462

  Geaghan, Sharon M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cord blood sampling; Fetal biochemistry; Fetal blood; Fetal laboratory reference values

Indexed keywords

ANEUPLOIDY; ARTICLE; FETAL WELL BEING; GENOTYPE; HUMAN; LABORATORY TEST; MEDICAL DECISION MAKING; ONTOGENY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK ASSESSMENT;

BLOOD TRANSFUSION, INTRAUTERINE; CORDOCENTESIS; FEMALE; FETAL DISEASES; FETOSCOPY; FETUS; HUMANS; LASER THERAPY; LIGHT COAGULATION; PREGNANCY; PRENATAL DIAGNOSIS; REFERENCE STANDARDS; REFERENCE VALUES; RISK ASSESSMENT;

EID: 79955146741     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.03.015     Document Type: Article

References (20)

1. Adzick N.S., Thorn E.A., Spong C.Y., Brock J.W., Burrows P.K., M.S., Johnson M.P., Howell L.J., Farrell J.A., Dabrowiak M.E., Sutton L.N., Gupta N., Tulipan N.B., D'Alton M.E., Farmer D.L. A randomized trial of prenatal versus postnatal repair of myelomeningocele. NEJM Feb. 9 2011, [Epub ahead of print].
2. Crumbleholme T.M., Harrison M.R., Longaker M.T., Langer J.C. Prenatal diagnosis and management of bilateral hydronephrosis. Pediatr Nephrol 1988, 2:334-342.
3. Deprest J.A., Flake A.W., Gratacos E., Ville Y., Hecher K., Nicolaides K., Johnson M.P., Luks F.I., Adzick N.S., Harrison M.R. The making of fetal surgery. Prenat Diagn 2010 Jul, 30:653-667.
4. Quintero R.A., Bornick P.W., Morales W.J., Allen M.H. Selective photocoagulation of communicating vessels in the treatment of monochorionic twins with selective growth retardation. Am J Obstet Gynecol 2001, 185:689-696.
5. Queenan J.T., Tomai T.P., Serdar H.U., et al. Deviation in amniotic fluid optical density at a wavelength of 450nm in Rh-immunized pregnancies from 14 to 40weeks' gestation: a proposal for clinical management. Am J Obstet Gynecol 1993, 168:1370-1376.
6. Loew M.P., Zimmerman B., Hansen W. Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care center. Am J Obstet Gynecol 2004, 190:358.
7. Swamy G., Simhan H., Siglin H., et al. The clinical utility of fetal fibronection. Am J Obstet Gynecol 2001, 185:S136.
8. Ashwood E.R. Standards of laboratory practice: evaluation of fetal lung maturity. National Academy of Clinical Biochemistry. Clin Chem 1997, 43:211-214. Review.
9. Gareri J., Klein J., Koren G. Drugs of abuse testing in meconium. Clin Chim Acta 2006, 366:101-111.
10. Gourley G.R., Kreamer B., Arend R. Excremental studies in human neonates. Identification of zinc coproporphyrin as a marker for meconium. Gastroenterology 1990, 00:1705-1709.
11. Invasive Prenatal Testing for Aneuploidy ACOG practice bulletin no. 88. Am College Obstetricians Gynecologists 2007, 110:1459-1465.
12. Soothill P.W., Ajayi R.A., Campbell S., Ross E.M., Candy D.C.A., Snijders R.M., Nicolaides K.H. Relationship between fetal academia at cordocentesis and subsequent neurodevelopment. Ultrasound Obstet Gynecol 1992, 2:80-83.
13. Chan D., Caprara D., Blanchette P., Klein J., Koren G. Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. Clin Biochem 2004, 37:429-438.
14. Chen C., David B.H., Wood B., Warzynski M.J. Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection. Cytom (Clinical Cytometry) 2002, 50:285-290.
15. Warzynski M.J. A flow cytometric "hemoglobin F" test to replace the Kleihauer-Betke slide test: background and practical considerations for implementation. AML Interact 1999, 4:1-2.
16. Lo Y.M., Tein M.S.C., TZe K.L., Haines C.J., Tse N.L., Poon P.M.K., Wainscoat J.S., Johnson P.L., Chang A.M.Z., Hjelm N.M. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998, 62:768-775.
17. Geaghan S. Hematologic values and appearances in the healthy fetus. Neonate Child Clin Lab Med Diagn Pediatr Hematol 1999, 19:1-37.
18. Gozzo M.L., Noia G., Barbaresi G., Colacicco L., Serraino M.A., De Santis M., Lippa S., Calla C., Caruso A., Mancuso S., Giardina B. Reference Intervals for 18 clinical chemistry analytes in fetal plasma samples between 18 and 40 weeks of pregnancy. Clin Chem 1998, 44:683-685.
19. Bokenkamp A., Dieterich C., Dressler F., Muhlhaus K., Gembruch U., Bald R., Kirschstein M. Fetal serum concentration of cystatin C and beta2-microglobulin as predictors of postnatal kidney function. Am J Obstet Gynecol 2001, 185:468-475.
20. Slovak J., Macke M., Chudoba D., Hubi W., Hill M., Starka L. Amniotic fluid 17-hydroxyprogesterone in early pregnancy. J Steroid Biochem Mol Biol 1994, 51:315-318.